Inhaled GM-CSF for autoimune pulmonary alveolar proteinosis

Francesco Bonella (Essen, Germany)

Source: Short video statement 2020
Number: 4
Disease area: -

Video

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Francesco Bonella (Essen, Germany). Inhaled GM-CSF for autoimune pulmonary alveolar proteinosis. Short video statement 2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment of severe pulmonary alveolar proteinosis using inhaled GM-CSF
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010

Pulmonary alveolar proteinosis
Source: Respipedia Article
Year: 2017

Pulmonary alveolar proteinosis
Source: Eur Respir Rev 2011; 20: 98-107
Year: 2011



Pulmonary alveolar proteinosis
Source: Eur Respir Mon; 2009: 46: 208–224
Year: 2009

Rituximab therapy in autoimmune pulmonary alveolar proteinosis
Source: Eur Respir J 2009; 33: 1503-1506
Year: 2009



Treatment of pulmonary alveolar proteinosis (PAP) with administration of GM-CSF
Source: Eur Respir J 2002; 20: Suppl. 38, 447s
Year: 2002

Our cases with pulmonary alveolar proteinosis
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018

Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis
Source: Eur Respir J 2012; 39: 777-780
Year: 2012


PAS-negative pulmonary alveolar proteinosis
Source: Annual Congress 2008 - Rare clinical cases
Year: 2008

Peripheral alveolar nitric oxide concentration reflects alveolar inflammation in autoimmune pulmonary alveolar proteinosis
Source: ERJ Open Res, 4 (1) 00071-2017; 10.1183/23120541.00071-2017
Year: 2018



Pulmonary alveolar proteinosis and idiopathic pulmonary hemosiderosis
Source: International Congress 2019 – CCC Airway diseases
Year: 2019



Successful treatment by GMCSF of pulmonary alveolar proteinosis relapsing after a first GMCSF course
Source: Eur Respir J 2004; 24: Suppl. 48, 670s
Year: 2004

Pulmonary alveolar proteinosis: from classification to therapy
Source: Breathe, 16 (2) 215; 10.1183/20734735.0018-2020
Year: 2020



The role of apoptosis in idiopathic pulmonary alveolar proteinosis
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006


The benefits of whole lung lavage in pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 23: 503-505
Year: 2004


Lung cysts in pulmonary alveolar proteinosis.
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018

Surfactant dysfunction and alveolar proteinosis
Source: ERS Course 2019 - Summer school of paediatric respiratory medicine 2019
Year: 2019

Surfactant dysfunction and alveolar proteinosis
Source: ERS Course 2018 - Summer school of paediatric respiratory medicine
Year: 2018